Cargando…
Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity
Immune checkpoint inhibitors (ICIs) are a class of drug that produces durable and sustained anti-tumour responses in a wide variety of malignancies. The exponential rise in their use has been mirrored by a rise in immune-related adverse events (IrAEs). Knowledge of such toxicities, as well as effect...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378048/ https://www.ncbi.nlm.nih.gov/pubmed/37504362 http://dx.doi.org/10.3390/curroncol30070502 |